Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

ClinicalTrials.gov ID: NCT05297448

Public ClinicalTrials.gov record NCT05297448. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study RNLC3132 is a Phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of rifaximin SSD-40mg IR for the delay of the first episode of overt hepatic encephalopathy (OHE) decompensation in liver cirrhosis, defined by the presence of medically controlled ascites.

Study identification

NCT ID
NCT05297448
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
466 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 3, 2022 (Actual)
Primary completion
Jan 2026 (Estimated)
Completion
Jan 2026 (Estimated)
Last update posted
Sep 10, 2025

2022 – 2026

United States locations

U.S. sites
90
U.S. states
25
U.S. cities
73
Facility City State ZIP Site status
Bausch Site 591 Homewood Alabama 35209 —
Bausch Site 445 Chandler Arizona 85224 —
Bausch Site 453 Sun City Arizona 85351 —
Bausch Site 587 Tucson Arizona 85715 —
Bausch Site 550 Bakersfield California 93309 —
Bausch Site 415 Coronado California 92118 —
Bausch Site 585 Covina California 91722 —
Bausch Site 585 Covina California 91723 —
Bausch Site 592 Fresno California 93720 —
Bausch Site 582 Lancaster California 93534 —
Bausch Site 590 Long Beach California 90808 —
Bausch Site 414 Los Angeles California 90067 —
Bausch Site 405 Orange California 92868 —
Bausch Site 482 Valencia California 91355 —
Bausch Site 575 Colorado Springs Colorado 80907 —
Bausch Site 425 Doral Florida 33122 —
Bausch Site 449 Hialeah Florida 33012 —
Bausch Site 558 Hialeah Florida 33012 —
Bausch Site 418 Hialeah Florida 33013 —
Bausch Site 468 Hollywood Florida 33024 —
Bausch Site 495 Miami Florida 23229 —
Bausch Site 543 Miami Florida 33032 —
Bausch Site 479 Miami Florida 33125 —
Bausch Site 428 Miami Florida 33126 —
Bausch Site 470 Miami Florida 33134 —
Bausch Site 486 Miami Florida 33144 —
Bausch Site 552 Miami Florida 33165 —
Bausch Site 594 Miami Florida 33165 —
Bausch Site 456 Miami Florida 33175 —
Bausch Site 458 Miami Florida 33176 —
Bausch Site 435 Miami Florida 33186 —
Bausch Site 452 Miami Lakes Florida 33016 —
Bausch Site 431/443 Ocala Florida 34471 —
Bausch Site 450 Ocala Florida 34471 —
Bausch Site 446 Ocoee Florida 34761 —
Bausch Site 421 Orange City Florida 32763 —
Bausch Site 596 Orlando Florida 32808 —
Bausch Site 537 Palmetto Bay Florida 33157 —
Bausch Site 407 Port Orange Florida 32127 —
Bausch Site 454 Wellington Florida 33467 —
Bausch Site 429 Zephyrhills Florida 33542 —
Bausch Site 577 Macon Georgia 31201 —
Bausch Site 475 Gurnee Illinois 60031 —
Bausch Site 588 South Bend Indiana 46635 —
Bausch Site 466 West Des Moines Iowa 50266 —
Bausch Site 524 Topeka Kansas 66606 —
Bausch Site 457 Lafayette Louisiana 70503 —
Bausch Site 531 Marrero Louisiana 70072 —
Bausch Site 488 Metairie Louisiana 70006 —
Bausch Site 413 New Orleans Louisiana 70125 —
Bausch Site 442 Shreveport Louisiana 71105 —
Bausch Site 583 Greenbelt Maryland 20770 —
Bausch Site 463 Flowood Mississippi 39232 —
Bausch Site 460 Jefferson City Missouri 65109 —
Bausch Site 598 Florham Park New Jersey 07932 —
Bausch Site 597 Freehold New Jersey 07728 —
Bausch Site 411 Sparta New Jersey 07871 —
Bausch Site 455 Toms River New Jersey 08755 —
Bausch Site 436 East Syracuse New York 13057 —
Bausch Site 401 The Bronx New York 10467 —
Bausch Site 427 Asheville North Carolina 28801 —
Bausch Site 494 Monroe North Carolina 28112 —
Bausch Site 422 Smithfield North Carolina 27577 —
Bausch Site 410 Dayton Ohio 45414 —
Bausch Site 580 Liberty Township Ohio 45044 —
Bausch Site 403 Springboro Ohio 45066 —
Bausch Site 472 Westlake Ohio 44145 —
Bausch Site 581 Allentown Pennsylvania 18104 —
Bausch Site 400 Harrisburg Pennsylvania 17110 —
Bausch Site 576 Philadelphia Pennsylvania 19104 —
Bausch Site 484 Providence Rhode Island 02905 —
Bausch Site 599 Columbia South Carolina 29204 —
Bausch Site 480 Summerville South Carolina 29486 —
Bausch Site 423 Chattanooga Tennessee 37421 —
Bausch Site 434 Chattanooga Tennessee 37421 —
Bausch Site 579 Hermitage Tennessee 37076 —
Bausch Site 600 Union City Tennessee 38261 —
Bausch Site 406 Dallas Texas 75390 —
Bausch Site 519 Denison Texas 75929 —
Bausch Site 437 Houston Texas 77074 —
Bausch Site 447 Humble Texas 77346 —
Bausch Site 448 San Marcos Texas 78130 —
Bausch Site 409 Waco Texas 76712 —
Bausch Site 416 Wichita Falls Texas 76301 —
Bausch Site 402 Burlington Vermont 05401 —
Bausch Site 559 Norfolk Virginia 23502 —
Bausch Site 424 Richmond Virginia 23226 —
Bausch Site 490 Richmond Virginia 23229 —
Bausch Site 595 Richmond Virginia 23236 —
Bausch Site 404 Roanoke Virginia 24014 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05297448, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05297448 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →